Picroside II (P-II), one of the main active components of scrophularia extract, which have anti-oxidative, anti-inflammatory effects, but its effect on hyperhomocysteinemia (HHcy) induced endothelial injury remains to be determined. Here, we test whether P-II protects HHcy-induced endothelial dysfunction against oxidative stress, inflammation and cell apoptosis. In vitro study using HUVECs, and in hyperhomocysteinemia mouse models, we found that HHcy decreased endothelial SIRT1 expression and increased LOX-1 expression, subsequently causing reactive oxygen species generation, up-regulation of NADPH oxidase activity and NF-κB activation, thereby promoting pro-inflammatory response and cell apoptosis. Blockade of Sirt1 with Ex527 or siRNASIRT1 increased LOX-1 expression, whereas overexpression of SIRT1 decreased LOX-1 expression markedly. P-II treatment significantly increased SIRT1 expression and reduced LOX-1 expression, and protected against endothelial cells from Hcy-induced oxidative injury, inflammation and apoptosis. However, blockade of SIRT1 or overexpression of LOX-1 attenuated the therapeutic effects of P-II. In conclusion, our results suggest that P-II prevents the Hcy induced endothelial damage probably through regulating the SIRT1/LOX-1 signaling pathway.
| INTRODUCTION
During the past decades, the convergence of clinical and basic evidence has demonstrated a fundamental role for endothelial dysfunction in pathogenesis and development of atherosclerotic diseases. 1 Homocysteine (Hcy) is derived from sulfur-containing and non-proteinogenic amino acid, and during the metabolism of methionine, it is formed in trace amount. Hyperhomocysteinemia (HHcy) can induces vascular endothelial injury, and has been determined to be one of the main risk factors for cardiovascular diseases, 2,3 but its exact mechanism remains unclear. 4 Lectin-like oxLDL receptor-1 (LOX-1) is an essential receptor for oxide low-density lipoprotein (oxLDL), 5 and plays a vital role in atherosclerotic process. 6 Much studies have shown that HHcy up-regulated human mononuclear and endothelial cells LOX-1 expression, 7, 8 which prompts reactive oxygen species (ROS) formation, 8, 9 induces pro-apoptotic signal transduction and nitric oxide (NO) catabolism, consequently causing oxidative injury and the endothelial cells death.
Picrorrhiza scrophulariiflora belongs to the plant family, scrophularia. The roots of this plant are of benefit, and as a traditional medicine, it is used for a number of conditions. 12, 13 Picroside II (P-II), one of the main active components of scrophularia extract, has shown its anti-oxidative, anti-inflammatory effects. [14] [15] [16] However, whether P-II could inhibit HHcy-induced endothelial injuries has not been studied.
In this study, we assess the protective effect of P-II on endothelial injury induced by HHcy and to determine its possible regulatory mechanisms.
| MATERIALS AND METHODS

| Drugs and reagents
Picroside II was purchased from Shanghai Standard Biotech (Shanghai, China) at a purity of 98%. It is stocked in dimethylsulfoxide (DMSO) solution and stored at −30°C. Hyperhomocysteinemia was purchased from Sigma (St. Louis, MO, USA). TRizol was obtained from Invitrogen (California, USA), the LOX-1, SIRT1 and Caspase-3 antibody were purchased from Santa Cruz Biotechnology Inc. (California, USA).
Hcy(D090821), DCFH-DA(D6883), DMSO(D5879), Hepes, SOD, MDA and NADPH oxidase activity kits were got from Sigma-Aldrich (USA). IL-6, IL -8, CXCL15 and TNF-α ELISA test kit were purchased from Shanghai Hong LiBiotechnology Company.
| Animals
In this study, a total of 50 C57BL mice were randomly divided into five experimental groups (10 . Briefly, after collagenase type I digestion, HUVECs were got from human umbilical veins, next it is cultured in medium 199 at 37°C in 5% CO 2 on 0.1% gelatin-coated culture flasks. The medium 199 contains 20% fetal calf serum, penicillin (100 U/mL), streptomycin (100 U/mL) and heparin (50 U/mL), and supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate and 5 ng/mL endothelial cell growth factor. When endothelial cells morphology appears "cobblestone" mosaic appearance and the presence of von Willebrand factor, it is identified.
Experiments were repeated in HUVECs from passage 2 to 7, with no differences observed between passages.
For experiments, HUVECs were divided into six groups randomly: a normal control group, a Hcy group, three P-II groups. Cells in the control group were incubated under the normal growth conditions. The HUVECs in the Hcy group were incubated with medium containing 100 μmol Hcy for 24 hours. In the P-II groups, the cells were preincubated with different concentrations (50 μg/mL, 100 μg/ mL, 200 μg/mL) of P-II for 24 h, and next it is incubated with 100 μmol Hcy for another 24 hours. 
| Cell viability
| Elisa
According to the manufacturer's instructions, SOD, MDA and chemokines in the supernatants or plasma were determined using ELISA kits. The levels of IL-6, IL-8, CXCL15 and TNF-α were measured by EnSpire Multimode Plate Readers (PerkinElmer, Fremont, CA, USA) at the absorbance at 450 nm.
Plasma levels of Hcy were measured using an Hcy detection kit (enzymatic cycling assay) on cobas c311 automatic biochemical analyser (Roche, Switzerland) . 
| Assay of intracellular ROS production
| Assay of NADPH oxidase activity
HUVECs and mouse aortic rings were harvested respectively.
NADPH-enhanced superoxide (O 2
−
) release in HUVECs or mouse aortic rings homogenate were calculated using lucigenin-enhanced chemiluminescence (CL), as previously described. 19 2.11 | Cellular MDA levels, SOD and catalase activity measurement
According to Cayman's assay kits instruction (Cayman Chemical, Ann
Arbor, MI, USA), the levels of MDA and the activity of SOD and catalase (CAT) in HUVECs homogenate were determined.
| Apoptosis assessment
By analysis of DNA fragmentation, apoptosis was examined using flow cytometry. 20 First, by using an Annexin V-FITC apoptosis detection kit, HUVECs were washed and double-stained. As we know, Annexin V can translocates from the internal to the external surface of the plasma membrane for its strong Ca 2+ -dependent affinity for phosphatidylserine (PS), and can detect apoptosis as a probe. Cells with the loss of membrane integrity will show red staining (propidium iodide, PI) throughout the nucleus, so the early apoptotic cells and the late apoptotic cells or necrotic cells are easily distinguished.
At room temperature, samples were incubated in the dark with Annexin V and PI for 15 minutes, and then they were analyzed by a FACS vantage SE flow cytometer quantitatively.
According to the caspase-3 assay kit (Calbiochem) instructions, the activities of caspase-3 were determined. 21 Briefly, we lysed and removed HUVECs from each group culture dishes, then washed twice with PBS, and pelleted by centrifugation. Next, cell pellets were treated with iced lysis buffer for 10 minutes. Then the suspensions were centrifuged for 10 minutes at 10 000 g, and the supernatants were transferred into a clear tube. Specific substrate
for caspase-3], was added into each tube, and the tubes were incubated for 2 hours at 37°C. The substrates were cleaved by caspases to form p-NA or AFC during incubation. Caspase-3 activities were calculated in a microtiter plate reader at 405 nm. In this study, assays were performed in triplicate and three independent experiments were performed.
| Statistical analysis
Differences between two groups were assessed using two-tailed t tests. Differences between more than two groups were assessed using one-way analysis of variance (ANOVA). To compare the interaction between two factors, two-way ANOVA tests were performed.
ANOVA, assessed by Bonferroni's post hoc test, was used when comparing more than two groups. All P < 0.05 were considered significant.
3 | RESULTS
| Characteristics of control and hyperhomocysteinaemic mice
There was no significant difference in initial body weight, systolic blood pressure, blood glucose among groups (all P > 0.05) ( Figure 1A -C). Plasma Hcy was increased in animals fed with 1% methionine, while reduced after treatment with P-II ( Figure 1D ).
| Picroside II attenuated vascular oxidative stress and inflammation in hyperhomocysteinaemic mice
As shown in Figure 2A , aortic endothelial NADPH oxidase activity was increased markedly in the HHcy mice group, however after treatment with P-II, it was decreased ( Figure 2A ). In addition, the level of plasma MDA in the HHcy mice was higher than that in the control group; however, treatment with P-II reversed HHcy-induced MDA increase ( Figure 2B ). The plasma SOD activity was markedly reduced in the HHcy mice group but was increased significantly after treatment with P-II ( Figure 2C ).
HHcy increased the expression of CXCL15 (human IL-8 homologous), TNF-α and IL-6 in the thoracic arteries of HHcy mice. Similarly, plasma levels of HHcy-associated inflammatory cytokines were also elevated. These changes in inflammatory cytokines were reversed after P-II treatment ( Figure 3A-F) . 
| Toxicity of picroside II to HUVECs
As shown in Figure 4C ,D, cell viability and cell apoptosis were not affected by treatment of HUVECs with 50 μg/mL, 100 μg/mL, 200 μg/mL of P-II for 48 hours. 
| Picroside II reduces HHcy-induced endothelial apoptosis in HUVECs
HHcy resulted in significant increase in HUVECs apoptosis. When cells were incubated with P-II, the apoptotic process was dramatically down-regulated in a concentration-dependent manner (Figure 7A) . The Caspase-3 activity displayed a similar change after adding P-II into the culture media of HUVECs. Western blotting showed the activity of Caspase-3 and the cleaved Caspase-3 levels were obviously elevated after HHcy. When the cells were pretreated with increasing concentrations of P-II, the Caspase-3 activity and the cleaved Caspase-3 levels were gradually decreased ( Figure 7B,C) .
F I G U R E 3
Picroside-II attenuated vascular inflammation in hyperhomocysteinaemic mice. The control mice (Control) had free access to water, and the hyperhomocysteinaemic mice (HHcy) were treated with 2% (m·v-1) methionine/drinking water for 3 months, then mice were divided into five groups for the next 2 month: the control mice, the 1% methionine group, the 1% methionine+P-II group (treated orally with P-II low dose:10 mg/kg, or high dose:60 mg/kg) or PBS every day, the 1% methionine+P-II treatment (high dose:60 mg/kg)+EX527 group, which 1.2 mM EX527 was diluted in phosphate-buffered saline (5 μl) was administered intravenously at 2 hours before P-II treatment. Interestingly, blockade of SIRT1 with siRNA SIRT1 decreased SIRT1 ( Figure 10A ) and increased LOX-1( Figure 10B ), whereas overexpressing of SIRT1 with SIRT1cDNA increased SIRT1 (Figure 10C,D) and decreased LOX-1 ( Figure 10E ).
| DISCUSSION
The results from our study showed that P-II, the main active ingredient in the root department of Chinese medicine Picrorhiza scrophulariiflora, could reduce HHcy-induced endothelial oxidase stress, inflammation and cell apoptosis in vitro and in vivo.
Emerging evidence suggests that HHcy accelerates atherosclerotic process as a result of increased oxidative stress. 22 Intracellular ROS levels are regulated by the balance between ROS formation and antioxidant enzymes. 23 In endothelial cells, NADPH oxidase is identified as a major source of oxidative stress. 24 These findings support a notion that P-II restores endothelial function by normalization of ROS and antioxidant defenses ( Figure 11 ).
ROS can activate NF-κB and enable nuclear translocation and subsequent regulation of proinflammatory molecules, including
The effect of P-II on vascular LOX-1 and SIRT1 expression in hyperhomocysteinaemic mice. The control mice (Control) had free access to water, and the hyperhomocysteinaemic mice (HHcy) were treated with 2% (m·v-1) methionine/drinking water for 3 months, then mice were divided into four groups for the next 2 month: the control mice, the 1% methionine group, the 1% methionine+P-II group (treated orally with high dose:60 mg/kg), the 1% methionine+P-II treatment (high dose:60 mg/kg)+EX527 group, which 1.2 mM EX527 was diluted in phosphate-buffered saline (5 μl) was administered intravenously at 2 hours before P-II treatment. (A) Vascular LOX-1 expression was determined by Western blot analysis; (B) Vascular SIRT1 expression was determined by Western blot analysis. (C, D) HUVECs were treated with different concentrations of P-II(50 μg/ml, 100 μg/ml, 200 μg/ml) for 48 hours, then cell viability (C) and cell apoptosis were measured (D). The data are presented as the mean ± SD (n = 10 in each group). *P < 0.05 as compared to control group mice, # P < 0.05 as compared to hyperhomocysteinaemic mice. | 469 cytokines, chemokines and adhesion molecules. Once NF-κB is activated, it translocates from the cell cytosol to the nucleus, binds to specific DNA sequences, and initiates transcription. These changes could alter gene expression, and induces the caspase-3 and final common effector proteases activation, eventually leading to apoptosis. 24 In this study, we found that ROS generation in HUVECs occurred within 20 minutes (data not shown), and within 4 hours of the incubation of Hcy, NF-κB was activated. P-II inhibited NF-κB activation and repressed HHcy-induced IL-6, IL-8, TNF-a expression.
We speculated that the protective effects of P-II against HHcyinduced endothelial damage might be through inhibiting intracellular ROS formation and proinflammatory cytokines production. Taken together, these observations strongly indicate that P-II elicits antioxidative and anti-inflammatory effects.
LOX-1, primary oxLDL receptor on endothelial cells, plays an important role in the pathogenesis of atherosclerosis. [26] [27] [28] OxLDL,
angiotensin II or other pro-inflammatory events have been reported to activate LOX-1 expression. 29 Recently, several studies have reported a link between LOX-1 and HHcy-induced endothelial dysfunction. expression in HUVECs were assessed using Western blot; (C) HUVECs were incubated with SIRT1 cDNA, the SIRT1 expression in HUVECs were determined by Western blot; (D, E) HUVECs were transfected with SIRT1 cDNA before exposure to Hcy, the expression of SIRT1(D)or LOX-1(E) in HUVECs were assessed by Western blot. (F) HUVECs were incubated with siRNA LOX-1, the LOX-1 expression in HUVECs were assessed using Western blot. The data are shown as the mean ± SD of six independent experiments. *P < 0.05 as compared to control group cells, # P < 0.05 as compared to Hcy-treated cells F I G U R E 1 1 Schematic illustration of the possible targeting and signaling by which P-II restore endothelial dysfunction induced by HHCY SIRT1, an important anti-atherosclerosis molecule, protects the cardiovascular system from degeneration and oxidative injuries. 31, 32 Previous reports have suggested that SIRT1 activation is an effective approach to manage HHcy-induced oxidative stress, 33, 34 and SIRT1 decreased the LOX-1 expression level and NF-κB activation. 8, 25 This statement is similar to our findings in the present study, as shown in results is given in Figure 11 .
In summary, the results from our study indicated that P-II prevented HHcy-induced LOX-1-mediated HUVECs injury, probably with its anti-oxidative and anti-inflammatory effects.
